Jarden Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)
Jarden Adjusts Integral Diagnostics' Price Target to AU$3.68 From AU$3.72, Keeps at Buy
Barclays Sticks to Their Hold Rating for Integral Ad Science (IAS)
What 5 Analyst Ratings Have To Say About Integral Ad Science
Integral Ad Science Price Target Announced at $10.00/Share by Scotiabank
Integral Ad Science Analyst Ratings
Barclays Keeps Their Buy Rating on Compania De Distribucion Integral Logista Holdings (0QWA)
Integral Ad Science Analyst Ratings
Loop Capital Markets Sticks to Their Buy Rating for Integral Ad Science (IAS)
Integral Ad Science: Buy Rating Affirmed Amid Anticipated Growth and Strategic Business Wins
Integral Ad Science Is Maintained at Buy by Craig-Hallum
Craig-Hallum Maintains Buy on Integral Ad Science, Lowers Price Target to $16
Integral Ad Science Analyst Ratings
Evercore ISI Remains a Buy on Integral Ad Science (IAS)
Analysts Offer Insights on Communication Services Companies: Integral Ad Science (IAS) and IHS Holding (IHS)
Integral Ad Science: Hold Rating Maintained Amid Mixed Q3 Results and Cautious Q4 Outlook
Barclays Sticks to Its Hold Rating for Integral Ad Science (IAS)
Compania De Distribucion Integral Logista Holdings (0QWA) Gets a Hold From Kepler Capital
Piper Sandler Keeps Their Buy Rating on Integral Ad Science (IAS)
Integral Diagnostics Price Target Raised 30% to A$3.67/Share by Jarden